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Background: Although the nonprescribed use of tranquilizers or sedatives by adolescents is a cause for concern in
many countries, there is a shortage of data from low and middle income countries (LAMIC). The present study aims
to estimate the prevalence of nonprescribed use of tranquilizers/sedatives by adolescents in Brazil, and to assess
how socioeconomic and demographic circumstances, as well as indicators of access to these substances are
associated with their use and with risk perception.
Methods: A cross-sectional study was conducted using a multi-stage probability sample of 18131 high school
students from public and private schools from all 27 Brazilian state capitals. A self-reporting questionnaire was used
to obtain information on social and economic circumstances, nonprescribed use of tranquilizers or sedatives and
risk perception of their use.
Results: Lifetime nonprescribed use of tranquilizers or sedatives was reported by 5% of respondents, more
commonly among females (OR: 2.19, 95% CI: 1.75-2.75) and those attending private schools (OR: 1.47, 95%
CI: 1.17-1.84). The use of tranquilizers/sedatives by relatives or friends was associated with nonprescribed use by
the participant (OR: 4.26, 95% CI: 3.46-5.23) and a majority of lifetime users obtained these substances from a family
environment (82%). Previous medical prescription was independently associated with nonprescribed use (OR: 6.61,
95% CI: 4.87-8.98) and with low risk perception (OR: 2.42, 95% CI: 1.12-5.24).
Conclusions: A substantial proportion of Brazilian adolescents use nonprescribed tranquilizers/sedatives. Easy
access to these substances seems to play an important role in this use and should be tackled by preventive and
treatment interventions.Background
The abuse of nonprescribed drugs among young people
appears to be a growing global problem. Among United
States youth, the use of prescription drugs exceed that of
illicit drugs, excluding cannabis [1]. A survey in the USA
showed that 6.5% of students had used nonprescribed
tranquilizers [2] whilst a study in 31 European countries
showed an average prevalence of 5.6% of those who had
ever used tranquilizer/sedatives with considerable vari-
ation between countries (from around 1.5% in Ukraine
and the United Kingdom to about 13% in Lithuania and
France) [3].* Correspondence: anareginanoto@gmail.com
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reproduction in any medium, provided the orThese substances may be seen as being “safer” than
illicit drugs since they are produced by pharmaceutical
companies, prescribed by physicians and widely con-
sumed by millions of people [4,5]. Their widespread
availability and pharmacological properties make them
particularly susceptible to abuse and dependence [6,7].
Evidence indicates that early use of psychotropic sub-
stances is likely to lead to higher levels of dependence
later in life along with the related health and social prob-
lems [8]. It is therefore particularly important to have
some better idea about their use among adolescents.
Although the misuse of prescription drugs is increas-
ing rapidly, data about nonprescribed use of prescrip-
tion drugs are not systematically collected in most
countries, especially in Low and Middle Income Coun-
tries (LAMIC), where policies for drug control are more
likely to fail. Being the largest country and mostl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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a huge market for the pharmaceutical industry, where
BZD are among the most widely prescribed drugs [9,10].
This study looks at the use of nonprescribed tranquil-
izers or sedatives among a sample of Brazilian high
school students. It is hoped that studies with Brazilian
adolescents can make a substantial contribution to the
knowledge gap about nonprescribed use of tranquilizers
by adolescents in LAMIC. The study used data from a
cross-sectional survey representative of high school stu-
dents (n = 18131) from all 27 Brazilian state capitals to
estimate the prevalence and describe the nonprescribed
use of tranquilizers/sedatives among Brazilian adoles-
cents and to assess how sociodemographics and eco-
nomic circumstances, as well as indicators of access to
tranquilizers/sedatives are associated with their misuse.
Methods
Participants/settings
A cross-sectional survey was conducted with a sample
of students attending private and public schools from
all the 27 Brazilian state capitals between March and
October 2010.
The study’s target population was designed as a repre-
sentative sample of high school students (10th to 12th
grade), with a two step random selection process. A list
of all private and public schools for each city included in
the study was obtained by the means of a national gov-
ernmental register. The schools were then stratified
according to the grade levels (middle schools only, high
schools only, and both levels). Based on a proportional
size sample, allocated according to the number of stu-
dents for each stratum, a randomized process selected
an average of 3 clusters (classroom) in each school. All
the students in the selected classroom were then invited
to participate in the survey and to answer the self-report
questionnaire. These methods have been previously de-
scribed elsewhere [11-13].
A total of 789 schools participated in this study, with a
school response rate of 86%. The student response rate
was 79.2% (20.5% were absent on the day of survey and
there was 0.3% refusal rate) with a total of 19230 ques-
tionnaires completed. We included a question for a ficti-
tious drug and 98 students attending high school who
answered it positively were excluded. The present study
is limited to high school students aged between 13 and
19 years old (n = 18131).
Procedures
The questionnaires were self-administered and were
completed inside the classroom without the presence of
any school staff and under the supervision of a team of
trained interviewers (all interviewers received 3 full days
of training). It took students 40 minutes on average tocomplete the questionnaire. To avoid contamination the
survey was conducted in a single visit to each school. All
procedures were standardized and applied in the same
way in each of the schools.
Ethics
Students were informed about the aims of the study and
were reassured that their participation was voluntary,
that they could choose not to participate at any time,
and that all the information provided was anonymous
and to be used for research purposes only. Written in-
formed consent was obtained from the principal of
schools. The study was approved by the Research Ethics
Committee of the Federal University of São Paulo.
Measures
Our pencil and paper questionnaire was based on a
World Health Organization instrument [14] and on the
European School Survey Project on Alcohol and Other
Drugs (ESPAD) questionnaire [15] which are specific for
self-report surveys about substance use among adoles-
cents attending school and have been previously used in
the Brazilian population [16].
Sociodemographic and economic circumstances
We obtained information on gender, age and type of
school (public or private). Socioeconomic status (SES)
was determined using a standard scale [17], which con-
siders the educational level of the head of the household,
possession of household assets (such as television, DVD
players, cars, refrigerators etc) and number of house-
keepers (such as driver, cleaner, gardener etc). This scale
categorizes participants into 5 social classes (from A to
E, where A is the highest and E the lowest).
Nonprescribed use of tranquilizers/sedatives
We limited our questions to the use of tranquilizers/sed-
atives without a medical prescription. We obtained in-
formation on lifetime use with the question: “Have you
ever taken a tranquilizer or sedative without a medical
prescription? E.g.: Diazepam, Dienpax®, Valium®, Lorax®,
Rohypnol®, Psicosedin®, Somalium®, Apraz®, Rivotril®, Al-
prazolam, Lexotan®, Dalmadorm®, Dormonid®, Broma
zepam, Frontal®, Olcadil® (DO NOT CONSIDER TEA
OR NATURAL MEDICINES)”. Similar questions were
asked regarding past year and past month use. We also
asked about the frequency that the substance was con-
sumed in the past month, the age of first use and about
the reasons for using tranquilizers or sedatives.
Indicators of access to tranquilizers/sedatives
All participants were asked about having received a
medical prescription for tranquilizers or sedatives and
about the use of these substances by a relative (parents,
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or sedatives users were asked how they obtained the medi-
cation with the following possible answers: “from a rela-
tive”, “from a friend”, “I get it from my home” and “other”.
Risk perception of nonprescribed use of tranquilizers/
sedatives
Students were asked about their risk perception of regu-
lar misuse of tranquilizers or sedatives. Responses
ranged from “no”, “mild”, “moderate” “severe” risk and “I
don’t know the risk”. These were further categorized
into “low risk” (no risk plus mild risk) and “high risk”
(moderate plus severe risk).
Data analyses
All analyses were performed in STATA Version 11
weighted to correct for unequal probability of selection
in the sample. The complex survey design took into
account the stratum (city and type of school), theTable 1 Sample characteristics, prevalence and correlates of n
among Brazilian adolescents (n = 18,131)
Total (n = 18131) Lifetime use prevalence (n =
Age (years) wgt% wgt% (95% CI)
13-15 35.6 4.5 (3.9-5.2)
16-19 64.4 5.3 (4.8-6.0)
Gender
Male 44.7 3.1 (2.6-3.6)
Female 55.3 6.6 (6.0-7.3)
SES
(lowest) C-E 36.0 3.7 (3.2-4.4)
B 35.3 5.8 (5.1-6.6)
(highest) A 10.4 9.3 (8.0-10.8)
Not reported 18.4 3.6 (2.7-4.7)
Type of school
Public 78.6 4.2 (3.7-4.7)
Private 21.4 8.1 (7.4-8.9)
Use of tranquilizers or sedatives by family members or friends
No 90.1 3.8 (3.4-4.2)
Yes 10.0 17.5 (15.3-20.0)
Received a prescription of tranquilizers or sedatives
No 90.0 3.6 (3.3-4.1)
Yes 2.6 28.8 (23.1-35.1)
Do not remember 7.4 13.5 (11.5-15.7)
Risk perception of nonprescribed tranquilizers or sedatives use
High 81.3 4.9 (4.4-5.4)
Low 7.2 8.4 (6.5-10.8)
Do not know 11.5 4.1 (3.1-5.5)
* Adjusted by all variables in the table.conglomerate (school as primary sampling unit), the
sampling weight and the probability of selecting the stu-
dent who answered the questionnaire.
Logistic regression was used to estimate the crude and
adjusted Odds Ratios of the association between all
sociodemographic characteristics, indicators of access
to tranquilizers/sedatives and student’s risk perception
with their lifetime use. Logistic regression models were
also used to estimate the association between having re-
ceived a prescription for a tranquilizer or a sedative in
the past and their perception of risk related to their mis-
use (adjusted for age, gender, social class, type of school
and tranquilizers or sedatives use by a family member
and/or friends). The latter analysis was limited to stu-
dents reporting lifetime use of these substances (n =
1026). We excluded 94 students who said “do not know”
for risk perception. Results are presented via weighted
proportions (wgt%), crude Odds Ratios (cORs), adjusted
Odds Ratios (aORs) and 95% confidence interval.onprescribed lifetime use of tranquilizers or sedatives
1076) Crude OR (95% CI) Adjusted OR* (95% CI) p value
1.00 1.00
1.18 (0.98-1.41) 1.37 (1.14-1.66) 0.001
1.00 1.00
2.22 (1.83-2.70) 2.19 (1.75-2.75) <0.001
1.00 1.00
1.58 (1.27-1.96) 1.36 (1.06-1.75) 0.015
2.61 (2.07-3.30) 1.77 (1.27-2.48) 0.001
0.95 (0.69-1.31) 1.06 (0.76-1.49) 0.734
1.00 1.00
2.02 (1.71-2.38) 1.47 (1.17-1.84) 0.001
1.00 1.00
5.43 (4.50-6.54) 4.26 (3.46-5.23) <0.001
1.00 1.00
10.66 (7.98-14.22) 6.61 (4.87-8.98) <0.001
4.11 (3.28-5.15) 3.58 (2.77-4.63) <0.001
1.00 1.00
1.79 (1.33-2.40) 1.53 (1.09-2.15) 0.015
0.84 (0.61-1.16) 1.07 (0.76-1.50) 0.692
Table 2 Nonprescribed use of tranquilizers or sedatives
by ever users (n = 1076)
wgt% (95% CI)
Past year use
66.6 (62.6-70.4)
Past month
30.0 (26.4-33.8)
Frequency of recent use (past month)
None 70.0 (66.1-73.6)
1 to 5 days 24.2 (21.2-27.4)
6 to 19 days 3.1 (2.0-5.0)
20 or more days 2.7 (1.5-4.9)
Reasons for use
To sleep/sleep better 47.9 (43.5-52.4)
To better deal with my anxiety 47.7 (43.5-51.9)
To get high 4.4 (2.8-6.7)
Sources for the first use
Given by a relative 52.7 (48.0-57.4)
Given by a friend 11.0 (8.0-15.0)
Available in the household 29.3 (25.5-33.3)
Others* 7.0 (4.5-10.6)
* Bought from drugstores without prescription, from drug dealers or used
false prescription.
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Table 1 describes the sample (n = 18131) and the lifetime
of nonprescribed tranquilizers users (n = 1076). Just over
half of the participants were female (55.3%), about two-
thirds were older adolescents (between 16 and 19 years
old), and the majority attended public schools (78.6%).
Thirty-six per cent of participants were in the lowest so-
cial classes (C-E).
Lifetime nonprescribed use of tranquilizers or seda-
tives was reported by 5.0% (95% CI: 4.6%-5.5%) of re-
spondents (n = 1076). One in 10 participants reported
the use of tranquilizers or sedatives by a family member
or a friend, 2.6% had received a prescription for these
substances in the past and 7.2% perceived their regular
use as low risk. Although the majority of participants
did not report use of tranquilizers or sedatives by a rela-
tive or friend and had never received a medical prescrip-
tion for these substances, the nonprescribed use of
tranquilizers or sedatives was more common among
those who responded positively to these two questions
(17.5% and 28.8% respectively).
We estimated the association between lifetime
nonprescribed use of tranquilizers or sedatives and
sociodemographic characteristics (age, gender, SES, type
of school); indicators of access to tranquilizers or seda-
tives (use by family/friends and having received a med-
ical prescription in the past) and risk perception of
nonprescribed use (Table 1). Adjusted analysis showed
that females (adjusted OR = 2.19; 95% CI: 1.75-2.75) and
older adolescents (adjusted OR = 1.37; 95% I 1.14-1.66)
were more likely to report lifetime nonprescribed use of
tranquilizers or sedatives. Wealthier students (from pri-
vate schools and from the highest social class) were
more likely to report lifetime nonprescribed use of tran-
quilizers or sedatives. Adolescents whose relatives or
friends use these substances were more likely to report
misuse compared with those who did not report such
use by family or friends (OR = 4.26; 95% CI: 3.46-5.23).
Having received a medical prescription for tranquilizers
or sedatives in the past increased by 6.61-fold (95% CI:
4.87-8.98) the odds of a participant to report
nonprescribed use. Compared to those reporting high
risk perception, participants with low risk perception
were also more likely to report lifetime nonprescribed
use.
Table 2 describes the pattern of consumption among
those who reported having ever used nonprescribed
tranquilizers or sedatives (n = 1076). Sixty six percent of
them (n = 703) reported nonprescribed use in the past
year (3.3% of the total sample) and nearly half of those
who used in the previous year reported misuse in the
last month (n = 303, 30% of lifetime users).
Among those who reported past-month use, most
reported having used tranquilizers or sedatives between1-5 days. A great majority (n = 854) of ever users (n =
1076) reported self-medication as a reason for their
nonprescribed use (47.7% to relieve anxiety symptoms
and 47.9% to help sleeping) and only 4.4% reported tak-
ing tranquilizers or sedatives to get high. Most of those
reporting lifetime use (52.7%) obtained tranquilizers or
sedatives from a relative, and 29.3% found it available in
the household. More than half of the students (57%)
who reported using tranquilizers or sedatives to get high
said that they had obtained the medication from friends
and a quarter had had their first use before they were
14 years (data not shown in the tables).
The association of having received a prescription in
the past with risk perception regarding regular
nonprescribed use was also estimated (adjusted by age,
gender, social class, type of school and use by family
member and/or friends). Those who received a prescrip-
tion for tranquilizers or sedatives in the past were more
likely to perceive as low the risk associated with regular
nonprescribed use (OR: 2.42, 95% CI: 1.12-5.24).
Discussion
In this sample of 18131 students from Brazilian private
and public schools, 5% reported lifetime use of
nonprescribed use of tranquilizers or sedatives, and 3.3%
had used them in the past year. Prevalence was twice as
high in females as males and more common in wealthier
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(use by family member and friends and having previ-
ously received a prescription) was associated with this
misuse and the substance was commonly obtained
within their own home (given by a relative, available in
the household). Despite nonprescribed use most
reported using to relieve anxiety symptoms and to sleep.
Prevalence of lifetime use of nonprescribed tranquil-
izers or sedatives by Brazilian students was very similar
to that reported among students in Europe (5.6%) [3]
and the USA (6.3%) [2]. Nationally representative sam-
ples of adolescents in the USA show lifetime prevalence
of sedatives to be less than 4% [18] and 2% of past-year
use of tranquilizers [18] which is lower than that found
among Brazilian students (3.3%). A previous survey
conducted in Brazil in 2004 and restricted to public
schools [19] found a prevalence of 4.1% among students
aged 15 years and above, which is slightly lower than
that found in our study.
Poverty is linked to poorer health behaviour and
health in general, including mental disorders [20,21]. De-
pression and substance misuse are important examples
of this disadvantaged cycle. Studies conducted with
nonprescribed use of prescription drugs have also shown
higher prevalence of their use among people in more
disadvantaged socioeconomic circumstances [18]. Our
findings however indicated the opposite; showing that
nonprescribed use of tranquilizers/sedatives was more
common among those in higher social classes and those
attending private schools. People in conditions of eco-
nomic hardship in LAMIC such as Brazil have less ac-
cess to health services, and therefore they and their
acquaintances are less likely to have access to any kind
of medicine.
It has generally been reported that nonprescribed drug
use is more common among females compared to males,
especially with regard to tranquilizers and sedatives [22].
The higher prevalence of nonprescribed use of tranquil-
izers or sedatives among females found in our study cor-
roborates studies in this aspect [3,23].
Moreover, in our study those who had previously re-
ceived a medical prescription for tranquilizers or seda-
tives were more likely to do a nonprescribed use of these
substances. A study conducted in the USA [24] found
that individuals aged 18 and over with a medical pre-
scription for anxiety were 61% more likely to use
nonprescribed anti-anxiety drugs compared to those
who did not receive a prescription. They were also more
likely to report abuse and/or dependence, even after
adjusting for sociodemographic variables and anxiety se-
verity. Receiving a prescription for a tranquilizer or a
sedative may encourage adolescents to use them again
when they face similar symptoms for which they re-
ceived a prescription. However, due to the nature of thisstudy, we cannot establish the direction of effect: indeed,
nonprescribed use may influence adolescents to seek a
medical prescription to maintain their use.
In our study most adolescents (more than 80%) who
reported nonprescribed use of tranquilizers or sedatives
had obtained these in their household environment. On
the other hand, it is possible that friends are more likely
to divert their prescription drugs for the purpose of
sensation-seeking. A high proportion of adolescents in
this sample who reported nonprescribed use for
sensation-seeking stated obtaining the medicine from
friends.
A medical prescription is legally required to purchase
tranquilizers and sedatives in Brazil for all age groups,
but because of failure in the law enforcement, purchas-
ing these substances without a prescription is an
established problem in Brazil [9,25]. However this is
likely to be more difficult for adolescents, because of
their age. In our study only a small proportion stated
spontaneously that they had purchased the medication
without a prescription.
Perceiving the use of a substance as no or low risk has
been found to be associated with their misuse [26], and
this was also found in our study for tranquilizers and
sedatives. However, little is known about the factors as-
sociated with risk perception of tranquilizers or sedatives
use. Our findings showed that among those who were
users of nonprescribed tranquilizers or sedatives, having
previously received a medical prescription was associ-
ated with low risk perception, even after adjusting for
their use by family or friends; this suggests that receiving
a medical prescription may have a stronger influence on
adolescents’ beliefs about the risks involved in the
nonprescribed use of tranquilizers or sedatives compared
to their relatives’ behaviour regarding use of these
substances.
Participants in this study represent students attending
private and public schools from the 27 Brazilian state
capitals and therefore caution is required when general-
izing our findings to students from the whole country
and most importantly, to students attending schools in
rural areas. However, we have a large sample size which
is representative of students from the biggest cities in
Brazil from all the country’s regions. Most studies on
this subject have been conducted in developed countries
and our findings add important information from a
LAMIC perspective. Another limitation is that we can
not extrapolate these findings to those students who
were absent on the day of the survey or to adolescents
who are not attending school in Brazil: some adolescents
who are involved in substance abuse are less likely to be
regular school attendees.
Self-report paper and pencil technique might lead to
over or under-estimation of true substance misuse
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we asked about the use of a ‘fictitious’ drug and those
who answered positively to this question were excluded
from the sample. Despite this potential limitation, an-
onymous self-report surveys are a very cost-effective
method to investigate substance use from an epidemio-
logical perspective [27]. Our sample was enriched by a
high response rate, since almost all of the students who
were invited to participate in our study, agreed to do so.
Conclusions
The results of this study showed that availability, low
risk perception and having received a medical prescrip-
tion in the past are important correlates of nonpres-
cribed use of tranquilizers or sedatives among Brazilian
students. These findings, together with the high preva-
lence we found, are relevant for policy makers in seeking
to develop strategies to prevent this behaviour, such as
improving medical education about the need for caution
in initiating tranquilizers or sedatives prescriptions in
general, and particularly for adolescents. Also, educa-
tional programmes developed to prevent nonprescribed
use of tranquilizers or sedatives among adolescents
should include information for adolescents and their
families regarding the risks associated with the misuse of
these substances.
In addition, doctors should inform their adult patients
that a prescription is for the named individual only and
the patient should be told of the risks of diverting the
prescription or of making tranquilizers and sedatives
available to other members of the family. Pharmacists
can also have an important role in preventing
nonprescribed use of these substances, not only advising
users about exclusivity of prescription, but also about
the care that should be taken regarding storage and dis-
posal of medicines at home.
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